Rees William A相关文献与解析，生知库 | 链接生命科学的每一步

Lau-Kilby Annie, Gunsior Michele, Bartczak Agata, Chyou Susan, Hester James, Sims Dorothy, Xiao Xiaodong, Pavlik Peter, Chen Yan, Casey Kerry A, Zerrouki Kamelia, Wang Qian, Borrok M Jack, Hansen Anna M, Rees William A

其它

Human

发表日期：2025

文献求助收藏

CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial

CD40配体拮抗剂达唑达利贝治疗干燥综合征：一项随机、双盲、安慰剂对照的II期试验

期刊:Nature Medicine

影响因子:50

doi:10.1038/s41591-024-03009-3

St Clair, E William; Baer, Alan N; Ng, Wan-Fai; Noaiseh, Ghaith; Baldini, Chiara; Tarrant, Teresa K; Papas, Athena; Devauchelle-Pensec, Valerie; Wang, Liangwei; Xu, Wenjing; Pham, Tuyet-Hang; Sikora, Keith; Rees, William A; Alevizos, Ilias

B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity

B细胞和水通道蛋白4抗体与视神经脊髓炎谱系疾病活动的关系

期刊:Annals of Clinical and Translational Neurology

影响因子:3.9

doi:10.1002/acn3.52171

Bennett, Jeffrey L; Pittock, Sean J; Paul, Friedemann; Kim, Ho Jin; Irani, Sarosh R; O'Connor, Kevin C; Patterson, Kristina R; Smith, Michael A; Gunsior, Michele; Mittereder, Nanette; Rees, William A; Cimbora, Daniel; Cree, Bruce A C

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder

发作时血清神经丝轻链水平可预测发作后残疾恶化，且可被伊奈利珠单抗减轻：视神经脊髓炎谱系障碍四种潜在生物标志物的分析

期刊:Journal of Neurology Neurosurgery and Psychiatry

影响因子:7.5

doi:10.1136/jnnp-2022-330412

Aktas, Orhan; Hartung, Hans-Peter; Smith, Michael A; Rees, William A; Fujihara, Kazuo; Paul, Friedemann; Marignier, Romain; Bennett, Jeffrey L; Kim, Ho Jin; Weinshenker, Brian G; Pittock, Sean J; Wingerchuk, Dean M; Cutter, Gary; She, Dewei; Gunsior, Michele; Cimbora, Daniel; Katz, Eliezer; Cree, Bruce A

神经科学

发表日期：2023

文献求助收藏

Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism

Inebilizumab 可降低视神经脊髓炎谱系障碍的风险，且与 FCGR3A 多态性无关

期刊:Annals of Clinical and Translational Neurology

影响因子:3.9

doi:10.1002/acn3.51911

Kim, Ho Jin; Aktas, Orhan; Patterson, Kristina R; Korff, Schaun; Kunchok, Amy; Bennett, Jeffrey L; Weinshenker, Brian G; Paul, Friedemann; Hartung, Hans-Peter; Cimbora, Daniel; Smith, Michael A; Mittereder, Nanette; Rees, William A; She, Dewei; Cree, Bruce A C

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial

B细胞耗竭与视神经脊髓炎谱系障碍发作风险之间的关联：一项来自N-MOmentum研究的探索性分析，该研究是一项双盲、随机、安慰剂对照、多中心2/3期试验。

期刊:EBioMedicine

影响因子:10.8

doi:10.1016/j.ebiom.2022.104321

Bennett, Jeffrey L; Aktas, Orhan; Rees, William A; Smith, Michael A; Gunsior, Michele; Yan, Li; She, Dewei; Cimbora, Daniel; Pittock, Sean J; Weinshenker, Brian G; Paul, Friedemann; Marignier, Romain; Wingerchuk, Dean; Cutter, Gary; Green, Ari; Hartung, Hans-Peter; Kim, Ho Jin; Fujihara, Kazuo; Levy, Michael; Katz, Eliezer; Cree, Bruce A C

Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis

伊奈比珠单抗在视神经脊髓炎谱系疾病、系统性硬化症或复发型多发性硬化症患者中的群体药代动力学模型

期刊:Clinical Pharmacokinetics

影响因子:4

doi:10.1007/s40262-021-01071-5

Yan, Li; Kimko, Holly; Wang, Bing; Cimbora, Daniel; Katz, Eliezer; Rees, William A

Pharmacodynamic modelling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders

伊奈利珠单抗在视神经脊髓炎谱系障碍患者中的药效学建模和暴露-反应评估

期刊:British Journal of Clinical Pharmacology

影响因子:3

doi:10.1111/bcp.15332

Yan, Li; Wang, Bing; She, Dewei; Mitchell, Ben; Criste, Ryan; Cimbora, Daniel; Katz, Eliezer; Rees, William A

神经科学

发表日期：2022

文献求助收藏

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

血清胶质纤维酸性蛋白：视神经脊髓炎谱系疾病的生物标志物

期刊:Annals of Neurology

影响因子:7.7

doi:10.1002/ana.26067

Aktas, Orhan; Smith, Michael A; Rees, William A; Bennett, Jeffrey L; She, Dewei; Katz, Eliezer; Cree, Bruce A C

神经科学

发表日期：2021

文献求助收藏

Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases

AMG 181（一种肠道特异性人抗α4β7单克隆抗体）治疗炎症性肠病的临床药理学研究

期刊:British Journal of Clinical Pharmacology

影响因子:3

doi:10.1111/bcp.12418

Pan, Wei-Jian; Köck, Kathleen; Rees, William A; Sullivan, Barbara A; Evangelista, Christine M; Yen, Mark; Andrews, Jane M; Radford-Smith, Graham L; Prince, Peter J; Reynhardt, Kaz O; Doherty, David R; Patel, Sonal K; Krill, Christine D; Zhou, Kefei; Shen, Jing; Smith, Lynn E; Gow, Jason M; Lee, Jonathan; Treacy, Anthony M; Yu, Zhigang; Platt, Virginia M; Borie, Dominic C

Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand.

AMG 329 的开发和临床前表征：一种中和 FLT3 配体的人类抗体

CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial

CD40配体拮抗剂达唑达利贝治疗干燥综合征：一项随机、双盲、安慰剂对照的II期试验

B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity

B细胞和水通道蛋白4抗体与视神经脊髓炎谱系疾病活动的关系

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder

发作时血清神经丝轻链水平可预测发作后残疾恶化，且可被伊奈利珠单抗减轻：视神经脊髓炎谱系障碍四种潜在生物标志物的分析

Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism

Inebilizumab 可降低视神经脊髓炎谱系障碍的风险，且与 FCGR3A 多态性无关

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial

B细胞耗竭与视神经脊髓炎谱系障碍发作风险之间的关联：一项来自N-MOmentum研究的探索性分析，该研究是一项双盲、随机、安慰剂对照、多中心2/3期试验。

Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis

伊奈比珠单抗在视神经脊髓炎谱系疾病、系统性硬化症或复发型多发性硬化症患者中的群体药代动力学模型

Pharmacodynamic modelling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders

伊奈利珠单抗在视神经脊髓炎谱系障碍患者中的药效学建模和暴露-反应评估

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

血清胶质纤维酸性蛋白：视神经脊髓炎谱系疾病的生物标志物

Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases

AMG 181（一种肠道特异性人抗α4β7单克隆抗体）治疗炎症性肠病的临床药理学研究